Artificial intelligence (AI) has the potential to expand the role of chest imaging in COVID-19 beyond diagnosis to enable risk stratification, treatment monitoring, and discovery of novel therapeutic targets. AI’s power to generate models from large volumes of information—fusing molecular, clinical, epidemiologic, and imaging data—may accelerate solutions to detect, contain, and treat COVID-19.